Response to cetuximab and gemcitabine-oxaliplatin in an advanced case of intrahepatic cholangiocarcinoma

被引：6

作者：

Bralet, MP ^{[1
]}

Bellin, MF

Guettier, C

Adam, R

Paule, B

机构：

[1] Hop Paul Brousse, Dept Pathol, APHP, Villejuif, France

[2] Hop Paul Brousse, Dept Radiol, APHP, Villejuif, France

[3] Hop Paul Brousse, Hepatobiliary Ctr, APHP, Villejuif, France

来源：

CLINICAL ONCOLOGY | 2006年 / 18卷 / 05期

关键词：

D O I：

10.1016/j.clon.2006.03.003

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 [肿瘤学];

摘要：

引用

页码：426 / 426

页数：1

共 4 条

[1]

Gemcitabine combined with oxaliplatin (GEMOX) in advanced biliary tract adenocarcinoma:: a GERCOR study [J].

André, T ;

Tournigand, C ;

Rosmorduc, O ;

Provent, S ;

Maindrault-Goebel, F ;

Avenin, D ;

Selle, F ;

Paye, F ;

Hannoun, L ;

Houry, S ;

Gayet, B ;

Lotz, JP ;

de Gramont, A ;

Louvet, C .

ANNALS OF ONCOLOGY, 2004, 15 (09) :1339-1343

[2]

Combining gemcitabine and capecitabine in patients with advanced biliary cancer: A phase II trial [J].

Knox, JJ ;

Hedley, D ;

Oza, A ;

Feld, R ;

Sin, LL ;

Chen, E ;

Nematollahi, M ;

Pond, GR ;

Zhang, J ;

Moore, MJ .

JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (10) :2332-2338

[3]

Amplification and overexpression of c-erbB-2, epidermal growth factor receptor, and c-met in biliary tract cancers [J].

Nakazawa, K ;

Dobashi, Y ;

Suzuki, S ;

Fujii, H ;

Takeda, Y ;

Ooi, A .

JOURNAL OF PATHOLOGY, 2005, 206 (03) :356-365

[4]

Cholangiocarcinoma: Molecular targeting strategies for chemoprevention and therapy [J].

Sirica, AE .

HEPATOLOGY, 2005, 41 (01) :5-15

← 1 →